Swallowable Capsule for Gut Microbe Sampling and Disease Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The human gastrointestinal tract remains poorly understood, with inaccessible regions and lack of technology to explore, discover, and experiment in vivo, leading to speculative medical treatments based on incomplete data, resulting in ineffective symptom-focused medications rather than addressing underlying disease causes.
Innovation Solution
Development of an in vivo gut technology system comprising three capsules (A, B, and C) that enable simultaneous sampling and analysis of microbes and chemical substances along the gastrointestinal tract, allowing for precise data collection, treatment, and perturbation of the gut environment to diagnose and treat diseases at the molecular and cellular levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Difficulty of detecting and measuring
If conventional endoscopy/colonoscopy instruments are used, then visible inspection of intestinal tract can be performed, but inaccessible regions remain unexplored and sample collection is extremely difficult
Solution Approach 1:
The patent replaces conventional mechanical endoscopy instruments with an ingestible capsule system that uses chemical sensing and biochemical analysis to detect and sample intestinal contents. The capsule collects samples through chemical interactions with intestinal fluids and tissues, enabling access to regions unreachable by mechanical probes while maintaining precise sampling capability through controlled chemical extraction methods.
Solution Approach 2:
The patent introduces chemical substances and biochemical mediators as intermediaries between the capsule sensor system and the intestinal environment. These chemical intermediaries facilitate sample collection by interacting with intestinal contents, enabling the capsule to extract and preserve samples from inaccessible regions through controlled chemical reactions rather than direct mechanical contact.
2Loss of information
If statistical inference methods are used to understand gut diseases, then broad patterns can be identified, but intrinsic models and physiological processes remain unknown
Solution Approach 1:
The patent implements continuous sampling and real-time analysis of intestinal contents throughout the capsule's journey through the gastrointestinal tract. This continuous measurement approach provides uninterrupted data streams that enable construction of intrinsic physiological models, replacing discrete statistical samples with continuous observational data that captures dynamic biological processes as they occur.
Solution Approach 2:
The patent substitutes statistical inference with direct biochemical measurement and molecular analysis. By using sensors that detect specific chemicals, metabolites, and molecular interactions in real-time, the system provides direct evidence of physiological processes rather than relying on statistical patterns, enabling precise characterization of biological mechanisms.
3Productivity
If symptom-focused treatments are developed, then patient symptoms can be managed, but underlying disease causes remain unidentified and treatments remain ineffective
Solution Approach 1:
The patent implements a feedback system where the capsule continuously monitors intestinal conditions, identifies disease markers and causal factors, and provides real-time information that can trigger targeted treatments. This feedback mechanism enables identification of underlying causes during the diagnostic phase, allowing treatment strategies to be adjusted based on actual physiological findings rather than relying on statistical associations.
Solution Approach 2:
The patent performs preliminary identification and characterization of disease causes and physiological processes during the diagnostic sampling phase. By analyzing intestinal contents, microbial compositions, and biochemical markers before treatment initiation, the system establishes a foundation of scientific understanding that guides subsequent targeted therapies, replacing reactive symptom management with proactive cause-based intervention.
Data Source
AI summary
This special gut microbe and chemical substance sampling technology, utilizing swallowable capsules, is for purpose of determining roles gut contents play in some 52 of most costly, in lives and dollars, of diseases with their known origin in the human gut. Gut microbes and substances are collected, analyzed, medicinal substances and objects deployed, and special provisions for attracting, capturing and preserving certain strains of microbes, and means for perturbing the gut environment and immune system are all intended to research, discover, and ultimately find both the causes and cures for the most devastating human diseases, and in the process, create gut microbiome profiles.